Montrusco Bolton Investments 13F: Cuts Zoetis (ZTS) Stake by $20M

Montrusco Bolton Investments has trimmed its position in Zoetis Inc. (NYSE:ZTS) by 26.3%, according to its latest Form 13F filing with the SEC. The investment fund sold 292,105 shares, reducing its holdings to 819,278 shares, valued at approximately $57.2 million as of the reporting period.

What Changed in Montrusco Bolton Investments' Zoetis Position

Montrusco Bolton Investments cut its stake in Zoetis by 26.3%, selling off 292,105 shares. The fund now holds 819,278 shares of the animal health company, down from its previous count of 1,111,383 shares.

Zoetis Inc. Stock Up 4.9%

Shares of Zoetis Inc. (NYSE:ZTS) traded near their previous close of $71.40 on Friday. The company, which specializes in animal health products, has a market capitalization of approximately $29.5 billion. Zoetis boasts a P/E ratio of 11.6 and a forward P/E of 10.9, with a beta of 0.729, indicating lower volatility compared to the broader market. The stock's 52-week range spans from $70.26 to $148.79, with a 50-day moving average of $75.23 and a 200-day moving average of $100.52.

Recent Earnings

Zoetis reported revenue of about $9.53 billion, though this marked a slight decline with a revenue growth rate of -0.2%. The company's net margin stands at 27.7%, and it posted a return on equity of 64.9%. Zoetis is set to release its next earnings report on November 3, 2026.

Dividend

Zoetis offers an annual dividend rate of $2.12, translating to a yield of 2.97%. The dividend payout ratio is a manageable 33.6%, allowing the company to maintain its dividend payments comfortably.

About Zoetis Inc.

Zoetis Inc. is a leading player in the animal health industry, based in Parsippany, New Jersey. The company focuses on developing, manufacturing, and commercializing a wide range of products for animals, including medicines, vaccines, and diagnostic solutions. Under the leadership of CEO Kristin C. Peck, Zoetis serves both companion animals like dogs and cats and livestock such as cattle and poultry. With about 14,500 employees, Zoetis is committed to advancing animal health across the globe.

Bottom Line

Montrusco Bolton Investments' decision to reduce its stake in Zoetis reflects a significant shift in its investment strategy. Investors often track such filings to gauge fund managers' confidence in a company, though it's important to remember that 13F filings are backward-looking and may not represent the current position. Zoetis remains a notable player in the animal health sector, offering a solid dividend and a strong market presence.